Sveikata
Sveikata yra susijusi su ekonominiu našumu ir klestėjimu bei yra svarbi visuomenės gerovei. Tam, kad pateikti asmeniui pritaikytus, į pacientą orientuotus metodus ir pasiūlyti prieinamą sveikatos priežiūrą, reikalinga efektyvi ir įrodymais grįsta politika.
„Technopolis Group“ padeda politikos formuotojams ir programų vadovams kurti į tikslą orientuotus metodus. Mūsų konsultantai padeda atidžiai įvertinti strategijos ir investicijųį sveikatos mokslus, technologijas ir inovacijas išlaidas, efektą ir poveikį. Turėdami žinių apie sveikatą ir gyvybės mokslus bei strateginio planavimo ir vertinimo patirties, siekiame prisidėti prie efektyvaus politikos formavimo.
The impact of collaboration: the value of UK medical research to EU science and health
The UK has a strong medical research community; the country’s withdrawal from the European Union (EU) can therefore be expected to have implications not only for the UK, but also for EU science and health. To better understand the UK’s contribution to medical research and patient health in the EU, a new study was commissioned…
Peržiūrėti ataskaitą
Review of the Product Development Partnerships Fund 2011-2014
Every year, poverty related diseases affect millions of people in the developing world. Yet, in the absence of clear profit potential, pharmaceutical companies are reluctant to invest in the development of treatments to fight these diseases. In response to this market failure, in the mid-1990s Product Development Partnerships (PDPs) emerged. PDPs use private sector approaches…
Peržiūrėti ataskaitą
Assessment of the performance and impact of the first programme of the European & Developing Countries Clinical Trials Partnership (EDCTP)
The European & Developing Countries Clinical Trials Partnership (EDCTP) was created in 2003 in response to the global health crisis caused by the three main poverty-related diseases HIV/AIDS, tuberculosis and malaria. The first EDCTP programme was aimed at accelerating the development of new or improved drugs, vaccines, microbicides and diagnostics against these three diseases. EDCTP…
Peržiūrėti ataskaitą
Assessing the research potential of access to clinical trial data
Clinical trials generate systematic and vital information about the efficacy, safety and quality of medical interventions. However, there has been much discussion about the degree to which trial results and the underpinning data are currently made available to researchers outside of the team that conducted the original trial. The primary aims of this study, commissioned…
Peržiūrėti ataskaitą